12-bromo-3-hydroxyimonoolean-28-13-olide
has antineoplastic activity
Also Known As:
Br-HIMOLID
Networked: 4
relevant articles (1 outcomes,
4 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Bednarczyk-Cwynar, Barbara:
2 articles
(10/2021 - 04/2017)
|
2. | Rubis, Blazej:
2 articles
(10/2021 - 01/2016)
|
3. | Zaprutko, Lucjusz:
2 articles
(10/2021 - 04/2017)
|
4. | Lisiak, Natalia:
2 articles
(04/2017 - 01/2016)
|
5. | Kaczmarek, Mariusz:
1 article
(10/2021)
|
6. | Kujawski, Jacek:
1 article
(10/2021)
|
7. | Lewicka, Izabela:
1 article
(10/2021)
|
8. | Lisiak, Natalia Magdalena:
1 article
(10/2021)
|
9. | PakuĊa, Martyna:
1 article
(04/2017)
|
10. | Paszel-Jaworska, Anna:
1 article
(04/2017)
|
Related Diseases
1. | Breast Neoplasms (Breast Cancer)
01/01/2016
- " Thus, we conclude that HIMOXOL (but not Br-HIMOLID) might reveal a significant potential against breast cancer cells, since it might efficiently induce the main autophagy mediator and prognostic factor, BECN1." 03/07/2023
- " In our study, we revealed that proliferation, cell cycle, apoptosis, autophagy, and also the migratory potential of HIMOXOL and Br-HIMOLID in breast cancer cells are mediated by ER (MCF7) and EGFR (MDA-MB-231) receptors. " 04/25/2017
- " This study is the first to report the antimigratory and anti-invasive activities of HIMOXOL and Br-HIMOLID in breast cancer cells." 03/07/2023
- " These are HIMOXOL and Br-HIMOLID, which were demonstrated to be capable of inducing apoptosis and autophagy or diminishing the migratory and invasive potential of breast cancer cells in vitro. " 04/25/2017
- " This paper reports a study on the role of two synthetic derivatives of oleanolic acid (OA), HIMOXOL and Br-HIMOLID, in the regulation of cell migration and invasion and the underlying molecular mechanisms of breast cancer cells. "
|
|
Related Drugs and Biologics